Dispertech logo — Nanoparticle characterization at high resolution

Dispertech

Nanoparticle characterization at high resolution

Founded 2019 The Netherlands The Netherlands 4 employees Seed Total: $1.00M Biotechnology, Life Sciences

General Information

Company Name Dispertech
Founded Year 2019
Location The Netherlands The Netherlands +1
Employees 4
Industries Biotechnology, Life Sciences
Funding Stage Seed
Social

Get notified when Dispertech moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Dispertech

Dispertech is a biotechnology startup based in The Netherlands, founded in 2019. The company's slogan "Nanoparticle characterization at high resolution" encapsulates its mission to unlock the power of extracellular vesicles as biomarkers, empowering researchers with new tools and services. Dispertech's technology, based on laser optics, allows single nanoparticle characterization with unprecedented accuracy. In December 14, 2022, the company secured a €1.00M Seed Round investment from Value Creation Capital. This investment signifies a vote of confidence in Dispertech's innovative approach and its potential to revolutionize nanoparticle characterization in the biotechnology sector.

Taxonomy: Nanoparticle characterization, Extracellular vesicles, Biomarkers, Laser optics, Single nanoparticle analysis, High resolution, Research tools, Services, Medical research, Investment opportunities

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1
Investor
14 Dec 2022

Dispertech Alternatives & Competitors

Dispertech vs

Pioneering precise nanoparticle characterization for unparalleled accuracy.

Series A
Dispertech vs
Aopia Biosciences
Aopia Biosciences United States

Revolutionizing Bio-nanoparticle purification

Non Equity Assistance
4 employees
Biotechnology, Health and Wellness
Dispertech vs
Nanolyze
Nanolyze Sweden

Ultra-sensitive technology for analyzing nanoparticle uptake and release of substances

Seed
7 employees

FAQ About Dispertech

Nanoparticle characterization at high resolution
Dispertech was founded in 2019.
Dispertech is headquartered in The Netherlands.
Dispertech operates in the following industries: Biotechnology, Life Sciences.
Dispertech has approximately 4 employees.
Dispertech has completed 1 funding round, raising a total of $1.00M. The latest funding stage is Seed.
Top alternatives and competitors to Dispertech include Manta Instruments, Aopia Biosciences, Nanolyze, Cyta Therapeutics, NanoCarrier Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Dispertech and Manta Instruments are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Dispertech and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes